AU7550994A - Sustained release oral compositions containing melatonin - Google Patents
Sustained release oral compositions containing melatoninInfo
- Publication number
- AU7550994A AU7550994A AU75509/94A AU7550994A AU7550994A AU 7550994 A AU7550994 A AU 7550994A AU 75509/94 A AU75509/94 A AU 75509/94A AU 7550994 A AU7550994 A AU 7550994A AU 7550994 A AU7550994 A AU 7550994A
- Authority
- AU
- Australia
- Prior art keywords
- sustained release
- compositions containing
- oral compositions
- release oral
- containing melatonin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9744393A | 1993-07-26 | 1993-07-26 | |
US097443 | 1993-07-26 | ||
PCT/US1994/008365 WO1995003043A1 (en) | 1993-07-26 | 1994-07-25 | Sustained release oral compositions containing melatonin |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7550994A true AU7550994A (en) | 1995-02-20 |
Family
ID=22263377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75509/94A Abandoned AU7550994A (en) | 1993-07-26 | 1994-07-25 | Sustained release oral compositions containing melatonin |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7550994A (en) |
WO (1) | WO1995003043A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6638963B1 (en) | 1990-12-04 | 2003-10-28 | Oregon Health And Science University | Methods for treating circadian rhythm disorders |
DE4443175A1 (en) * | 1994-12-05 | 1996-06-13 | Jenapharm Gmbh | New pulsatile drug form |
US5688520A (en) * | 1995-03-29 | 1997-11-18 | Minnesota Mining And Manufacturing Company | Transmucosal delivery of melatonin for prevention of migraine |
IL144900A (en) | 2001-08-14 | 2013-12-31 | Neurim Pharma 1991 | Melatonin and medicaments comprising it for use in treating primary insomnia and in the manufacture of such medicaments |
EP1656939A1 (en) * | 2004-11-10 | 2006-05-17 | Pooger Properties Limited | Use of melatonin in the manufacture of a medicament for treating cancer |
GB2434099A (en) * | 2006-01-12 | 2007-07-18 | Roger Coghill | Very low dosage melatonin compositions and their use in the treatment of the adverse effects of exposure to electromagnetic fields and radiation |
CA2683436C (en) | 2007-04-11 | 2016-07-26 | John A. Mccarty | Melatonin tablet and methods of preparation and use |
US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
US8691275B2 (en) * | 2011-01-28 | 2014-04-08 | Zx Pharma, Llc | Controlled-release melatonin compositions and related methods |
NL2015272B1 (en) | 2015-08-05 | 2017-05-02 | Versailles B V | Melatonin formulations and methods for preparation and use. |
CN109922795B (en) * | 2016-10-31 | 2021-10-08 | 纽里姆药物有限公司 | Melatonin small tablet and preparation method thereof |
US10849856B2 (en) | 2016-10-31 | 2020-12-01 | Neurim Pharmaceuticals Ltd. | Melatonin mini-tablets and method of manufacturing the same |
WO2019038586A1 (en) | 2017-08-19 | 2019-02-28 | Ftf Pharma Private Limited | Pharmaceutical composition of melatonin |
JP6813922B1 (en) * | 2019-12-10 | 2021-01-13 | ノーベルファーマ株式会社 | Melatonin-containing granules |
WO2021144403A1 (en) * | 2020-01-17 | 2021-07-22 | Société des Produits Nestlé S.A. | Dosage form with sustained release melatonin pellets |
WO2021187608A1 (en) * | 2020-03-18 | 2021-09-23 | ノーベルファーマ株式会社 | Novel granules and production method therefor |
US20240316057A1 (en) | 2021-01-15 | 2024-09-26 | Galventa Ag | Pulsatile release caffeine formulation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3466215D1 (en) * | 1983-05-18 | 1987-10-22 | Univ Monash | The use of melatonin for the manufacture of a medicament |
AU571922B2 (en) * | 1984-01-26 | 1988-04-28 | Schering Agrochemicals Limited | Veterinary implants comprising melatonin and derivatives thereof |
AU601736B2 (en) * | 1986-05-23 | 1990-09-20 | Sanofi Sante Nutrition Animale Sa | Coated veterinary implants |
US4945103A (en) * | 1989-01-17 | 1990-07-31 | Michael Cohen | Method of treating pre-menstrual syndrome |
ATE181670T1 (en) * | 1991-05-09 | 1999-07-15 | Neurim Pharma 1991 | MEDICINAL PRODUCTS CONTAINING MELATONIN |
-
1994
- 1994-07-25 WO PCT/US1994/008365 patent/WO1995003043A1/en active Application Filing
- 1994-07-25 AU AU75509/94A patent/AU7550994A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1995003043A1 (en) | 1995-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5804194A (en) | Oral compositions | |
AU7842794A (en) | Oral compositions | |
AU6725496A (en) | Peroxidase-activating oral compositions | |
AU4016095A (en) | Oral compositions | |
AU4928396A (en) | Oral compositions | |
AU3650895A (en) | Oral compositions | |
AU1118092A (en) | Sustained release compositions | |
AU3736295A (en) | Denture stabilizing compositions | |
AU5939394A (en) | Sustained release compositions | |
AU5151293A (en) | Oral hygiene composition | |
AU2372095A (en) | Oral compositions | |
AU6983594A (en) | Composition for oral cavity | |
AU6776494A (en) | Oral compositions | |
AU7727196A (en) | Oxygen generating compositions | |
AU7550994A (en) | Sustained release oral compositions containing melatonin | |
GB9400134D0 (en) | Oral composition | |
GB9513694D0 (en) | Oral compositions | |
GB9515597D0 (en) | Oral compositions | |
AU6464098A (en) | Dental composition | |
AU2739097A (en) | Enhanced zinc containing oral composition | |
AU7345094A (en) | Oral compositions | |
AU2427895A (en) | Oral compositions | |
AU7453496A (en) | Enhanced stannous oral composition | |
AU1096597A (en) | Oral compositions containing peroxide with stable colorant | |
AU4756996A (en) | Oral compositions |